UK
backs use of
Merck cancer immu**therapy after price discount
LONDON, Sept 7 (Reuters) - Britain's healthcare cost-effectiveness watchdog NICE on Monday recommended use of Merck's
immu**therapy drug Keytruda,
after the U.S. drugmaker promised to supply it to...
[IMG]http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=NL**nRdmhFE:483xVp_TF0I:V_ sGLiPBpWU[/IMG] [IMG]http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=NL**nRdmhFE:483xVp_TF0I:F7 zBnMyn0Lo[/IMG]
[IMG]http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/NL**nRdmhFE[/IMG]